Prosecution Insights
Last updated: November 08, 2026
Application No. 19/114,439

REPLACEABLE PATCH FOR WEARABLE TRAINING COMPUTER AND WEARABLE TRAINING COMPUTER

Non-Final OA §102§103
Filed
Mar 22, 2025
Priority
Oct 05, 2022 — GB 2214630.2 +1 more
Examiner
EISEMAN, ADAM JARED
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Polar Electro Oy
OA Round
1 (Non-Final)
55%
Grant Probability
Moderate
1-2
OA Rounds
2y 4m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allowance Rate
346 granted / 628 resolved
-14.9% vs TC avg
Strong +28% interview lift
Without
With
+27.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 12m
Avg Prosecution
34 currently pending
Career history
668
Total Applications
across all art units

Statute-Specific Performance

§101
4.9%
-35.1% vs TC avg
§103
52.2%
+12.2% vs TC avg
§102
20.7%
-19.3% vs TC avg
§112
17.7%
-22.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 628 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55. Information Disclosure Statement The information disclosure statement (IDS) submitted on 3/22/2025 was received and placed in the record on file. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Objections Claim 3 is objected to because of the following informalities: it recites “the replaceable batch” but should recite “the replaceable patch”. Appropriate correction is required. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “Guiding means” in claims 1-8, 10 and 12-15 “Optical guiding means” and “mechanical guiding means” in claims 9 Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. The claim interpretation of the identified 112(f) invoked limitations are as follows: “guiding means” are described as mechanical guiding means or optical guiding means as described on page 15, line 32 – page 14, line 33 and depicted in figures 6A-6C; and equivalents thereof. The mechanical guiding means and optical guiding means are interpreted as described in page 15, line 32 – page 14, line 33 and depicted in figures 6A-6C which includes a mechanical feature on the patch and/or training computer such as protrusions to receive an edge of the corresponding element; magnetic couplings; positioning mark(s); the optical window; and combinations thereof; and equivalents thereof If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-4, 8-12 and 14-15 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by James et al (US 2023/0168194 A1). Regarding claims 1-4, 8-12 and 14; James discloses a replaceable patch (LSPR sensor, element 20) for a wearable training computer (smartwatch, element 10), the replaceable patch for the wearable training computer, comprising: a plasmonic bioactive layer (LSPR film coating, element 26) for a surface plasmonic resonance measurement (paragraphs [0013]-[0031], specifically [0014]; figures 1-3); at least one optical window for a light of at least one photoplethysmogram sensor of the wearable training computer (wherein the LSPR sensor qualifies as an optical window as it allows the light from the smart watch light source go into the sensor and allows for receiving of the reflected light by the photodetector (paragraphs [0013]-[0031]; figures 1-3); and guiding means (stand, element 30) for guiding positioning of the replaceable patch on the wearable training computer such that the light of the at least one photoplethysmogram sensor can pass the at least one optical window (paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Further regarding claim 2; James discloses the plasmonic bioactive layer comprises an array of plasmonic sensor elements, wherein each sensor element is configured to be separately activated by an electric input from the wearable training computer (wherein there is a 2-dimensional array of metal nanoparticles in the sensor that are activated by the LED light which is generated in the LED by an electric input from the wearable training computer; paragraphs [0013]-[0031], specifically [0016]; figures 1-3). Further regarding claim 3; James discloses the guiding means (element 30) are further configured to guide positioning of the replaceable patch on the wearable training computer such that a light of a surface plasmonic sensor head of the wearable training computer can be focused on the activated sensor element (paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Further regarding claim 4; James discloses the array of the electrically active plasmonic sensor elements comprises at least one subset with a first receptor agent for measuring a first biochemical substance (wherein a 2-D array of metal nanoparticles is disclosed, and thus inherently includes at least one subset which measures a first biochemical substance; paragraphs [0013]-[0031], specifically [0016]-[0017]; figures 1-3). Further regarding claim 8; James discloses the plasmonic bioactive layer comprises a metallic layer (paragraphs [0013]-[0031], specifically [0016]; figures 1-3). Further regarding claim 9; James discloses the guiding means comprises at least optical guiding means and/or mechanical guiding means (comprises mechanical attachment means; paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Further regarding claim 10; James discloses the replaceable patch further comprises attaching means for removably attaching the replaceable patch on the wearable training computer, wherein the attaching means comprises a mechanical attaching and/or a chemical attaching (paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Further regarding claim 11; James discloses the guiding means comprises the attaching means (paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Further regarding claim 12; James discloses the replaceable patch is configured to cover, when coupled with the wearable training computer, substantially a whole bottom surface of the wearable training computer (wherein the patch is aligned with the bottom of the smartwatch via the alignment means; paragraphs [0013]-[0031]; figures 1-3). Further regarding claim 14; James discloses the replaceable patch further comprises at least one microfluidic channel for guiding sweat from the user's skin to the plasmonic bioactive layer (paragraphs [0013]-[0031], specifically [0018], [0023], [0026]; figures 1-2). Regarding claim 15; James discloses a wearable training computer, the wearable training computer comprising: a surface plasmonic sensor (LSPR sensor, element 20) configured to measure biomolecular composition of a sample from a user of the wearable training computer (paragraphs [0013]-[0031], specifically [0014]; figures 1-3); a photoplethysmogram sensor (smartwatch optoelectronics comprising LED and photodetector) configured to measure cardiac activity of the user of the wearable training computer (paragraphs [0013]-[0031]; figures 1-3); and guiding means (stand, element 30) for guiding positioning of a replaceable patch on the wearable training computer such that a light of the photoplethysmogram sensor can pass at least one optical window of the replaceable patch (wherein the LSPR sensor qualifies as an optical window as it allows the light from the smart watch light source go into the sensor and allows for receiving of the reflected light by the photodetector; paragraphs [0013]-[0031], specifically [0022] and [0024]; figures 1-3). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 5 and 6 are rejected under 35 U.S.C. 103 as being unpatentable over James as applied to claims 1 and 2 above, and further in view of Jornet et al (US 2021/0121065 A1). Regarding claims 5 and 6; James is described in the rejection of claims 1 and 2 above. As noted above, James discloses the use of a 2-D array of metal nanomaterials which can be modified to selectively adsorb a desired target biomolecule (paragraph [0014]-[0017]). However, James does not explicitly disclose that the plasmonic sensor elements comprise a plurality of subsets with a plurality of receptor agents for measuring a plurality of biochemical substances non-invasively from sweat. Jornet teaches a similar system for utilizing electrically active plasmonic sensor elements comprising a plurality of subsets with a plurality of receptor agents for measuring a plurality of biochemical substances is a biofluid (paragraphs [0028]-[0030]; figure 3). Therefore, it would have been obvious to one of ordinary skill in the art at the time of filing to modify James 2-D array of plasmonic sensor elements to comprise a plurality of subsets with a plurality of receptor agents for measuring a plurality of biochemical substances as taught by Jornet in order to monitor a plurality of target biomolecules with a single sensor array. Further regarding claim 6; neither James or Jornet explicitly disclose the biochemical substance to be measured comprises at least one of glucose, lactate or cortisol. However, the examiner takes official notice that it would have been obvious to one of ordinary skill in the art at the time of filing to monitor known biochemical substances of interest in biofluids including well known target substances including glucose, lactate and/or cortisol as well known and conventionally monitored biomolecules/analytes. Claim 7 and 13 are rejected under 35 U.S.C. 103 as being unpatentable over James as applied to claim 1 above, and further in view of Heikenfeld et al (US 2018/0020981 A1). Regarding claim 7 and 13; James is described in the rejection of claim 1 above. James further discloses the sensor includes a fluid transport/handling system for transporting the fluid across the plasmonic sensor elements (paragraphs [0018] and [0026]). However, James does not explicitly disclose the specifics of the fluid handling system or that the fluid handling system comprises at least one pilocarpine element for inducing sweat generation of a user of the wearable training computer, the pilocarpine element configured to be activated by an electric input from the wearable training computer. Heikenfeld discloses a similar modular biofluid sensing system which measures the biofluid from the skin of the user comprising a sweat stimulating component for inducing sweat generation of a user of the system for causing a biofluid to flow across a sensor via a fluid handling/transport system, wherein the pilocarpine element is configured to be activated by an electric input from the system controller (paragraph [0028],[0035],[0039],[0043],[0050],[0052] and [0053]; figures 2A-4). Therefore, it would have been obvious to one of ordinary skill in the art at the time of filing to modify James fluid handling/transport system to include at least one pilocarpine element for inducing sweat generation of a user of the wearable training computer wherein the pilocarpine element is configured to be activated by an electrical input from the controller as taught by Heikenfeld in order to generate sweat to test for analyte in the biofluid. Furthermore, it would have been obvious to one of ordinary skill in the art at the time of filing that the fluid handling/transport system of the James/Heikenfeld combination would be controlled by the controller of the system which is the wearable training computer (i.e. smartwatch). Further regarding claim 13; the James/Heikenfeld combination is described above. Heikenfeld discloses the pilocarpine element generates sweat by iontophoresis via an iontophoresis electrode coupled to the controller (paragraph [0051]). Therefore, it would have been obvious to one of ordinary skill in the art at the time of filing to modify the James/Heikenfeld combination patch to further comprise at least one opening for electric coupling between the wearable training computer and a skin of the user of the wearable training computer as taught by Heikenfeld in order to generate iontophoresis for sweat generation to measure a target molecule. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: US 2018/0313754 A1 to Cappo et al; discloses a miniature, field portable, surface plasmon resonance apparatus and applications in the detection of biological agents. US 2020/0155047 A1 to Rogers et al; discloses a microfluidic system for epidermal sampling and sensing. US 2017/0238804 A1 to Hartley; discloses a continuous and non-continuous in-vivo spectroscopy. US 2021/0241900 A1 to Reykhert et al; discloses a smart patch for monitoring health metrics. US 2015/0247797 A1 to Oberg; discloses a microchannel plasmon resonance biosensor. US 2021/0190683 A1 to James et al; discloses a equilibrium plasmonic analyte sensing apparatus and method. US 2019/0307370 A1 to Shinohara et al; discloses a biological material measuring apparatus. US 2025/0032010 A1 to Tian et al; discloses a wearable plasmonic paperfluidics apparatus for continuous biofulid analysis. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ADAM J EISEMAN whose telephone number is (571)270-3818. The examiner can normally be reached Monday - Friday (7:00 AM - 4:00 PM). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jacqueline Cheng can be reached at 571-272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ADAM J EISEMAN/ Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Mar 22, 2025
Application Filed
Oct 02, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779180
GUIDE WIRE AND METHOD FOR PRODUCING GUIDE WIRE
3y 1m to grant Granted Nov 03, 2026
Patent 12778434
METHOD AND DEVICE FOR NON-INVASIVE DETECTION OF CENTRAL ARTERIAL PRESSURE AND OTHER INTRALUMINAL LARGE ARTERIAL PRESSURES
2y 0m to grant Granted Nov 03, 2026
Patent 12758128
BIOSENSOR APPARATUS
3y 2m to grant Granted Oct 13, 2026
Patent 12751701
APPARATI, INSTRUMENTS, SYSTEMS AND METHODS OF USE AND ASSEMBLY
2y 10m to grant Granted Oct 06, 2026
Patent 12733832
Bio-impedance Measurement Device and Bio-impedance Measurement Method
2y 6m to grant Granted Sep 15, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
55%
Grant Probability
83%
With Interview (+27.6%)
3y 12m (~2y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 628 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month